Adverum Biotechnologies, Inc. Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. for May 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 96,000 | |
May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.02 | 500 | 19,009 | 7,000 | 7.5 K to 7 K (-6.67 %) |
May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 38.30 | 102 | 3,906 | 40,737 | 40.8 K to 40.7 K (-0.25 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 37.59 | 304 | 11,428 | 40,839 | 41.1 K to 40.8 K (-0.74 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.52 | 786 | 28,703 | 41,143 | 41.9 K to 41.1 K (-1.87 %) |
May 22 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 38.88 | 5,196 | 202,043 | 402,056 | 407.3 K to 402.1 K (-1.28 %) |
May 22 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 38.16 | 11,679 | 445,644 | 407,252 | 418.9 K to 407.3 K (-2.79 %) |
May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 96,500 | |
May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.87 | 500 | 19,435 | 7,000 | 7.5 K to 7 K (-6.67 %) |
May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 19 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 35.31 | 1,192 | 42,086 | 41,929 | 43.1 K to 41.9 K (-2.76 %) |
May 18 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.00 | 4,525 | 162,886 | 552,989 | 557.5 K to 553 K (-0.81 %) |
May 18 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 35.36 | 17,975 | 635,666 | 557,514 | 575.5 K to 557.5 K (-3.12 %) |
May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 97,000 | |
May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 35.31 | 500 | 17,656 | 7,000 | 7.5 K to 7 K (-6.67 %) |
May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
May 13 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 34.94 | 715 | 24,984 | 575,489 | 576.2 K to 575.5 K (-0.12 %) |
May 13 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Option Exercise | M | 3.15 | 285 | 898 | 236,500 | |
May 13 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Sell | S | 34.94 | 285 | 9,959 | 9,000 | 9.3 K to 9 K (-3.07 %) |
May 13 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Buy | M | 3.15 | 285 | 898 | 9,285 | 9 K to 9.3 K (+3.17 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 34.29 | 132 | 4,527 | 43,121 | 43.3 K to 43.1 K (-0.31 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 33.70 | 552 | 18,604 | 43,253 | 43.8 K to 43.3 K (-1.26 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 32.80 | 508 | 16,662 | 43,805 | 44.3 K to 43.8 K (-1.15 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Option Exercise | M | 3.15 | 715 | 2,252 | 236,785 | |
May 12 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Sell | S | 34.91 | 715 | 24,964 | 9,000 | 9.7 K to 9 K (-7.36 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Buy | M | 3.15 | 715 | 2,252 | 9,715 | 9 K to 9.7 K (+7.94 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 34.91 | 1,785 | 62,323 | 576,204 | 578 K to 576.2 K (-0.31 %) |
May 11 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 33.05 | 17,250 | 570,092 | 418,931 | 436.2 K to 418.9 K (-3.95 %) |
May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 97,500 | |
May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 33.28 | 500 | 16,638 | 7,000 | 7.5 K to 7 K (-6.67 %) |
May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
May 07 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 30.00 | 25,000 | 750,093 | 283,988 | 309 K to 284 K (-8.09 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Option Exercise | M | 0.19 | 5,000 | 950 | 22,500 | |
May 06 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Sell | S | 30.87 | 5,000 | 154,349 | 11,320 | 16.3 K to 11.3 K (-30.64 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Buy | M | 0.19 | 5,000 | 950 | 16,320 | 11.3 K to 16.3 K (+44.17 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Option Exercise | M | 3.15 | 2,500 | 7,875 | 237,500 | |
May 06 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Sell | S | 31.59 | 2,500 | 78,972 | 9,000 | 11.5 K to 9 K (-21.74 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Buy | M | 3.15 | 2,500 | 7,875 | 11,500 | 9 K to 11.5 K (+27.78 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 30.87 | 1,192 | 36,797 | 44,313 | 45.5 K to 44.3 K (-2.62 %) |
May 05 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 32.37 | 20,000 | 647,306 | 577,989 | 598 K to 578 K (-3.34 %) |